(Reuters) - Insys Therapeutics Inc has agreed to pay $4.5 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed a highly addictive fentanyl-based cancer pain drug for off-label uses.
from Reuters: U.S. http://ift.tt/2vLgymr
No comments:
Post a Comment